Literature DB >> 16896118

Parasitic co-infections: does Ascaris lumbricoides protect against Plasmodium falciparum infection?

Laurent Brutus1, Laurence Watier, Valérie Briand, Virginie Hanitrasoamampionona, Hélène Razanatsoarilala, Michel Cot.   

Abstract

A controlled randomized trial of antihelminthic treatment was undertaken in 1996-1997 in a rural area of Madagascar where populations were simultaneously infected with Ascaris lumbricoides and Plasmodium falciparum. Levamisole was administered bimonthly to 164 subjects, randomized on a family basis, whereas 186 were controls. While levamisole proved to be highly effective in reducing Ascaris egg loads in the treated group (P < 10(-3) at all bimonthly visits), subjects more than 5 years of age, treated with levamisole had a significant increase in their P. falciparum densities compared with controls (P = 0.02), whereas there was no effect of anti-helminthic treatment on children 6 months to 4 years of age. The demonstration of a clear negative interaction between Ascaris infection and malaria parasite density has important implications. Single community therapy programs to deliver treatments against several parasitic infections could avoid an increase of malaria attacks after mass treatment of ascariasis.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16896118

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


  30 in total

1.  Associations between peripheral Plasmodium falciparum malaria parasitemia, human immunodeficiency virus, and concurrent helminthic infection among pregnant women in Malawi.

Authors:  Michael C Thigpen; Scott J Filler; Peter N Kazembe; Monica E Parise; Allan Macheso; Carl H Campbell; Robert D Newman; Richard W Steketee; Mary Hamel
Journal:  Am J Trop Med Hyg       Date:  2011-03       Impact factor: 2.345

2.  Coinfection with Plasmodium falciparum and Schistosoma haematobium: additional evidence of the protective effect of Schistosomiasis on malaria in Senegalese children.

Authors:  Magali Lemaitre; Laurence Watier; Valérie Briand; André Garcia; Jean Yves Le Hesran; Michel Cot
Journal:  Am J Trop Med Hyg       Date:  2013-12-09       Impact factor: 2.345

Review 3.  Immunomodulation in Plasmodium falciparum malaria: experiments in nature and their conflicting implications for potential therapeutic agents.

Authors:  Anne E P Frosch; Chandy C John
Journal:  Expert Rev Anti Infect Ther       Date:  2012-11       Impact factor: 5.091

4.  Concurrent helminthic infection protects schoolchildren with Plasmodium vivax from anemia.

Authors:  Gisely Cardoso Melo; Roberto Carlos Reyes-Lecca; Sheila Vitor-Silva; Wuelton Marcelo Monteiro; Marilaine Martins; Silvana Gomes Benzecry; Maria das Graças Costa Alecrim; Marcus Vinícius Guimarães Lacerda
Journal:  PLoS One       Date:  2010-06-21       Impact factor: 3.240

5.  Does treatment of intestinal helminth infections influence malaria? Background and methodology of a longitudinal study of clinical, parasitological and immunological parameters in Nangapanda, Flores, Indonesia (ImmunoSPIN Study).

Authors:  Aprilianto E Wiria; Margaretta A Prasetyani; Firdaus Hamid; Linda J Wammes; Bertrand Lell; Iwan Ariawan; Hae Won Uh; Heri Wibowo; Yenny Djuardi; Sitti Wahyuni; Inge Sutanto; Linda May; Adrian J F Luty; Jaco J Verweij; Erliyani Sartono; Maria Yazdanbakhsh; Taniawati Supali
Journal:  BMC Infect Dis       Date:  2010-03-25       Impact factor: 3.090

6.  Hookworm-induced persistent changes to the immunological environment of the lung.

Authors:  Joshua J Reece; Mark C Siracusa; Teresa L Southard; Cory F Brayton; Joseph F Urban; Alan L Scott
Journal:  Infect Immun       Date:  2008-05-27       Impact factor: 3.441

7.  Plasmodium falciparum and helminth coinfection in a semi urban population of pregnant women in Uganda.

Authors:  Stephen D Hillier; Mark Booth; Lawrence Muhangi; Peter Nkurunziza; Macklyn Khihembo; Muhammad Kakande; Moses Sewankambo; Robert Kizindo; Moses Kizza; Moses Muwanga; Alison M Elliott
Journal:  J Infect Dis       Date:  2008-09-15       Impact factor: 5.226

8.  Rationale for the coadministration of albendazole and ivermectin to humans for malaria parasite transmission control.

Authors:  Kevin C Kobylinski; Haoues Alout; Brian D Foy; Archie Clements; Poom Adisakwattana; Brett E Swierczewski; Jason H Richardson
Journal:  Am J Trop Med Hyg       Date:  2014-07-28       Impact factor: 2.345

9.  Advances in parasite control in Africa: from basic science to translation.

Authors:  Francisca Mutapi
Journal:  J Parasitol Res       Date:  2012-07-19

10.  Malaria and related outcomes in patients with intestinal helminths: a cross-sectional study.

Authors:  Abraham Degarege; Mengistu Legesse; Girmay Medhin; Abebe Animut; Berhanu Erko
Journal:  BMC Infect Dis       Date:  2012-11-09       Impact factor: 3.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.